echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Cardiovasc Diabetol: Predictive significance of NGAL and sdLDL–C in coronary artery disease in patients with type 2 diabetes

    Cardiovasc Diabetol: Predictive significance of NGAL and sdLDL–C in coronary artery disease in patients with type 2 diabetes

    • Last Update: 2023-01-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Although type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) share many pathological and physiological features, few studies have evaluated the predictive
    power of novel biomarkers for the onset and progression of CAD in patients with T2DM ≥ 65 years of age.
    In addition, ≥ 65-year-old T2DM patients are prone to CAD
    .
    Therefore, it is important
    to look for new biomarkers of CAD development in patients with T2DM.

    This was a retrospective cohort study that enrolled 579 patients with T2DM aged ≥ 65 years in a row, of whom 177 had major cardiovascular and cerebrovascular adverse events (MACCE: cardiovascular or cerebrovascular death, acute coronary syndrome, coronary stenting, and stroke)
    during follow-up.
    Univariate and multivariate analyses were used to analyze the correlation of variables with MACCE occurrence, and Spearman rank correlation analysis was used to evaluate the correlation
    between neutrophil gelatinase-associated lipolipids (NGAL) and low-density low-density low-density lipoprotein-cholesterol (sdLDL-C).
    The receiver operating characteristics (ROC) curve was used to determine the predictive value
    of elevated NGAL and sdLDL-C in ≥ 65-year-old T2DM patient.


    Correlation of NGAL with sdLDL-C levels and other indicators

    At a median follow-up of 48 months, the levels of NGAL, SDLL-C, HEMOGLOBIN A1c (HbA1c), LDL-C, and apolipoprotein B (ApoB) were significantly increased in the MACCE-positive group, while the levels of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) were significantly reduced
    。 NGAL was positively correlated with body mass index (BMI) (r=0.
    391, P=0.
    001), triglycerides (TG) (r=0.
    228, P=0.
    032), high-sensitivity CRP (hsCRP) (r=0.
    251, P=0.
    007), and neutrophils (r=0.
    454, P=0.
    001).
    The levels of sdlDL-C were positively correlated with LDL-C (r=0.
    413, P=0.
    001), TG (r=0.
    432, P=0.
    001), ApoB (r=0.
    232, P=0.
    002), and negatively correlated
    with HDL-C (r=-0.
    362, P=0.
    031) and ApoA–I (r=-0.
    402, P=0.
    001).


    Predicting the subject operating characteristic curve for MACCE

    Age-adjusted Cox regression analysis showed that NGAL and sdLDL–C were independently correlated
    with the occurrence of MACCE.
    ROC curve analysis showed that NGAL and sdLDL-C predicted the risk of MACCE (AUC=0.
    87, P<0.
    001).

    In summary, in patients with T2DM aged ≥ 65 years, higher NGAL and sdLDL-C levels were significantly and independently associated with MACCE risk, and their clinical value was higher than that of other lipid biomarkers or other chronic inflammatory indicators, so it is expected to be the most effective predictor
    of MACCE assessment.

    Original source:

    Chen, Y.
    , Fu, Y.
    , Wang, S.
    et al.
    Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged?≥?65 years.
    Cardiovasc Diabetol 21, 252 (2022).
    https://doi.
    org/10.
    1186/s12933-022-01668-5

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.